Secondary mutations at I1171 in the ALK gene confer resistance to both Crizotinib and Alectinib (original) (raw)

Secondary mutations at I1171 in the ALK gene confer resistance to both Crizotinib and Alectinib

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014

Gouji Toyokawa

Fumihiko Hirai

Yukito Ichinose

Yukito Ichinose

Masafumi Yamaguchi

Takashi Seto

Tomoyoshi Takenaka

Gouji Toyokawa hasn't uploaded this paper.

Let Gouji know you want this paper to be uploaded.

Ask for this paper to be uploaded.